These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 1484986)

  • 21. [Role of prostate-specific antigen in prostatic carcinoma. Validity of an integrated methodologic approach and morpho-biological correlations].
    Tomasino RM; Lo Bianco A; Cacciatore M; Pavone C; Carreca I; Morello V; Salvato M; Florena AM; Pavone-Macaluso M
    Pathologica; 1989; 81(1072):109-26. PubMed ID: 2475847
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Clinical and pathological study of tumor marker in benign prostatic hypertrophy and incidental prostatic cancer].
    Sakai N; Ogawa T; Ishibashi Y; Fukuoka H; Sakanishi S
    Hinyokika Kiyo; 1991 Jun; 37(6):589-94. PubMed ID: 1716409
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serial measurements of tissue polypeptide specific antigen (TPS), PSA, PAP and CEA serotest values in treated patients with primary and metastatic prostate cancer.
    Tarle M
    Anticancer Res; 1993; 13(3):769-77. PubMed ID: 7686362
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of prostate-specific antigen as a marker for adenocarcinoma of the prostate.
    Barak M; Mecz Y; Lurie A; Gruener N
    J Lab Clin Med; 1989 May; 113(5):598-603. PubMed ID: 2469756
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Determination of tumor markers in the diagnosis of prostatic cancer].
    Casas Terrón E; Mari Ruiz M; Molina Andreu E
    Arch Esp Urol; 1993 Mar; 46(2):99-103. PubMed ID: 7684585
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [The value of the serum level of the prostate-specific antigen in prostatic pathology].
    Théodon P; Rymer JC; Chopin D; Kouyoudjian JC; Abbou CC; Auvert J
    Ann Urol (Paris); 1988; 22(3):199-205. PubMed ID: 2456713
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [The significance of serum prostate-specific antigen, gamma-seminoprotein and prostatic acid phosphatase as prostate cancer markers].
    Yamaguchi K; Tanaka M; Kitagawa N; Kotake T; Yanagi S; Ito H
    Hinyokika Kiyo; 1989 Jun; 35(6):987-91. PubMed ID: 2478006
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Clinical significance of tumor markers in prostatic carcinoma--comparative study of prostatic acid phosphatase, prostate specific antigen and gamma-seminoprotein].
    Yoshiki T; Okada K; Oishi K; Yoshida O
    Hinyokika Kiyo; 1987 Dec; 33(12):2044-9. PubMed ID: 2452559
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prostate specific antigen. Experimental and clinical observations.
    Huber PR; Schnell Y; Hering F; Rutishauser G
    Scand J Urol Nephrol Suppl; 1987; 104():33-9. PubMed ID: 2449722
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Tumor markers in prostate cancer].
    Kuriyama M
    Gan To Kagaku Ryoho; 1994 Sep; 21(12):1915-22. PubMed ID: 7521999
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Carcinoma of the prostate. Serum tumour markers.
    Ekman P
    Scand J Urol Nephrol Suppl; 1991; 139():15-8. PubMed ID: 1722588
    [TBL] [Abstract][Full Text] [Related]  

  • 32. PSA excess in the differential diagnosis of prostate carcinoma.
    Díaz F; Morell M; Rojo G
    Arch Esp Urol; 1997 May; 50(4):415-8. PubMed ID: 9219422
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Prognosis significance of prostatic markers in patients with prostatic adenocarcinoma undergoing total hormonal blockade].
    Regueiro López JC; Ruiz Alvarez Cienfuegos F; Leva Vallejo M; Requena Tapia MJ; Merchan García JA; Prieto Castro R; Alvarez Kindelan J
    Actas Urol Esp; 1995 May; 19(5):357-62. PubMed ID: 8659288
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Prostate-specific antigen (PSA): diagnostic and prognostic implications in the evaluation of carcinoma of the prostate].
    Lo Cigno M; Montanari F; Bercovich E; Soli M; Emili E; Dal Pozzo C; Platè L; Bianchi D
    Arch Ital Urol Nefrol Androl; 1989 Mar; 61(1):29-36. PubMed ID: 2469127
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Value of serum PSA and PAP measurement with newly developed latex turbidimetric immunoassay].
    Akino H; Tsuka H; Okada K; Tsuchiya Y; Matsubara M; Arimura K
    Hinyokika Kiyo; 1995 Jun; 41(6):439-45. PubMed ID: 7544063
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Diagnostic value of prostatic acid phosphatase and prostate-specific antigen in patients with prostatic cancer.
    Pagani F; Zambolin T; Bonora R; Panteghini M
    J Nucl Med Allied Sci; 1990; 34(4 Suppl):85-7. PubMed ID: 1709211
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Prostate specific antigen in serum of the patients with prostatic cancer].
    Akimoto S; Akakura K; Fuse H; Shimazaki J
    Hinyokika Kiyo; 1988 Apr; 34(4):636-42. PubMed ID: 2456678
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical characteristics and primary treatment of prostate cancer in Sweden between 1996 and 2005.
    Adolfsson J; Garmo H; Varenhorst E; Ahlgren G; Ahlstrand C; Andrén O; Bill-Axelson A; Bratt O; Damber JE; Hellström K; Hellström M; Holmberg E; Holmberg L; Hugosson J; Johansson JE; Petterson B; Törnblom M; Widmark A; Stattin P
    Scand J Urol Nephrol; 2007; 41(6):456-77. PubMed ID: 17934985
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Prostatic cancer developing after transurethral resection of the prostate for benign prostatic hyperplasia].
    Tanaka Y; Aoyama H; Momose H; Ono T; Samma S; Tanaka N; Akiyama T; Tani Y; Masuda Y; Matsuki H; Tani M; Tanaka M
    Hinyokika Kiyo; 2001 Jan; 47(1):11-4. PubMed ID: 11235214
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [The clinical use of the prostate-specific antigen in patients with prostatic cancer].
    Matveev BP; Sokolov AV; Bukharkin BV; Ledian KM; Tilk AE; Makarova GV
    Urol Nefrol (Mosk); 1991; (4):8-12. PubMed ID: 1719686
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.